Navigation Links
Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
Date:5/8/2012

BETHESDA, Md., May 8, 2012 /PRNewswire-iReach/ -- Reimbursement strategy has become an integral component of drug and device development and commercialization plan. For new product launches it is becoming critical to demonstrate clinical, safety, economic and quality of life benefits versus comparators to payers, providers and patients. Novel Health Strategies, LLC's presentations at ISPOR 2012 highlight these trends: 

IMPACT OF 2009-2011 GLOBAL HEALTH CARE REFORMS ON PRICING, ACCESS AND HEALTH OUTCOMES STRATEGY (UT2, Tuesday, June 5, 2012, Podium Presentation)

COST EFFECTIVENESS TRENDS OF HIGH BUDGET IMPACT DRUGS (2006-2012) (CE1, Monday, June 4, 2012, Podium Presentation)

DEVELOPING BUDGET IMPACT MODEL FOR RARE DISEASES: CASE IN POINT CUTANEOUS T-CELL LYMPHOMA (PCN30, Wednesday, June 6, 2012)

ELECTRONIC PATIENT REPORTED OUTCOMES AND DATA TOOL FOR CHRONIC DISEASE MANAGEMENT (PROCDIM): CASE IN POINT PROSTATE CANCER (PIH32, Tuesday, June 5, 2012)

ONCOLOGY DRUG PRICES IN THE UNITED STATES AND THE UNITED KINGDOM: IMPLICATIONS FOR PRICING STRATEGY AND DRUG ACCESS (PCN116, Wednesday, June 6, 2012)

SYSTEMATIC REVIEW OF CLINICAL EFFICACY AND SAFETY OUTCOMES OF ANTI-VEGF THERAPIES FOR METASTATIC COLORECTAL CANCER (PCN114, Wednesday, June 6, 2012)

SYSTEMATIC REVIEW OF INTERFERON FREE BASED REGIMENS FOR CHRONIC HEPATITIS C TREATMENT (PIN5, Wednesday, June 6, 2012)

TRENDS IN RATE AND COST OF HOSPITALIZATIONS DUE TO CHRONIC KIDNEY DISEASE (CKD) IN THE UNITED STATES (PUK13, Tuesday, June 5, 2012)

Relevant References:

*Targeted Cancer Therapies, Nature Reviews Drug Discovery 9, 427-428 (June 2010)
http://novelhealthstrategies.com/Targeted_Cancer_Therapies.pdf
*What's Fueling the Biotech Engine-2010 to 2011, Nature Biotechnology 29, 1083–1089 (2011)
http://www.nature.com/nbt/journal/v29/n12/abs/nbt.2060.html
*Impact of 2009-2011 Global Healthcare Reforms on Access, Pricing and Health Outcomes Strategy, June 2, 2012
http://www.ispor.org/meetings/washingtondc0512/Program_060512.asp#podiums3

About Novel Health Strategies
Novel Health Strategies, LLC (http://www.novelhealthstrategies.com) is an award winning team of experienced professionals with expertise in healthcare strategy, research, policy, publications, health economics and outcomes research, modeling, and pricing and market access strategy. Novel Health team has led strategy projects for majority of top 50 pharmaceutical, biotech and device companies. Novel Health has large network of internal and external stakeholders and has published several thought leading strategy perspectives, including the 'What's fueling the biotech engine' annual series in Nature Biotech, cited and quoted by more than two hundred peer-reviewed publications and agencies (FDA, EMA and others). Novel Health has presented industry trends and perspectives at ISPOR, AMCP and BIO meetings. To learn more about Novel Health team's experience, case studies and capabilities, contact at the address on this press release.

Media Contact: Saurabh Aggarwal, PhD Novel Health Strategies, LLC, (202) 618-9365, info@novelhealthstrategies.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Novel Health Strategies, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
3. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
4. IDM Pharma Announces Upcoming Clinical Data Presentations
5. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
6. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
7. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
8. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
9. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
10. Genmab Announces Upcoming Ofatumumab Studies
11. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in wound care advancements to physician colleagues, skilled nursing facility medical directors and ... the Treacherous Waters of Wound Care." , "At many of these conferences we ...
Breaking Medicine News(10 mins):